BDSX · CIK 0001439725 · FY2025 live · 2025-12-31
BIODESIX INC
View as
Model
Z″
FY2025
−19.59
Zone
Distress
Prior
—
Market DD
—
1y PD
—
−19.59
Classic Z −7.82
Z″ −19.59 · distress below 1.10, grey to 2.60, safe above.
Z″ factor contributions
X1 Working capital / assets
Short-term liquidity. Carries more weight in Z″ than in classic Z.
0.176.56 × = 1.13X2 Retained earnings / assets
Cushion from years of profits. Share buybacks can push this negative at otherwise healthy firms.
−5.693.26 × = −18.55X3 EBIT / assets
Operating return on assets. Highest weight in Z″.
−0.326.72 × = −2.14X4 Book equity / liabilities
Book equity versus the liability stack. Sales / assets is omitted so asset-light names are not punished for turnover.
−0.031.05 × = −0.03
Five-year path
Need two annual 10-Ks to draw a path. The desk will pull this issuer’s filings rather than invent a series.
Overview
rule-v1
BIODESIX INC is on Z″ at −19.59 (distress) for FY2025, from an SEC 10-K. Retained earnings / assets is the line that sets the print. This is the first live year on the desk. No market tape loaded. Z″ drops sales/assets so asset-light names are not punished for turnover. X4 is book equity on every name.
Book screen Distress; market PD —. Tape not priced — not a single default call.
Market DD · naive Merton
No market tape yet.
Pull a year of closes (Yahoo, Nasdaq if Yahoo is limited) and size equity from Nasdaq cap or EDGAR shares. Distance-to-default and 1-year PD stay blank until then.
Sector peers
Closest Z″ scores · 1st percentile in Healthcare.
KPI widgets
Current assets
$33M
Total assets
$87M
Current liabilities
$17M
Total liabilities
$90M
Working capital
$15M
Retained earnings
−$498M
EBIT
−$28M
Total sales
$88M
Book equity
−$2M
Accession 0001193125-26-076547. Live rank is the latest 10-K on EDGAR (FY2025, period 2025-12-31). Z″ is the live score. View as does not rewrite the live rank. X4 is book equity. Pulled 12 Sept 2026.